SpringWorks Therapeutics logo

SpringWorks Therapeutics

SpringWorks Therapeutics is a clinical-stage biopharmaceutical company that takes a precision medicine approach in acquiring, developing and commercializing medicines for patient populations that are suffering from rare diseases and cancer.

2

Funding Rounds

$228.0m

Money raised

Overview

SpringWorks Therapeutics is a clinical-stage biopharmaceutical company that takes a precision medicine approach in acquiring, developing and commercializing medicines for patient populations that are suffering from rare diseases and cancer.

Funding series

Funding Series Analysis

The company SpringWorks Therapeutics has raised a total of $125m in funding over 2 rounds.

Key Insights:

  • SpringWorks Therapeutics Series B round, April 2019: $125m
  • SpringWorks Therapeutics funding round, September 2017: $103m
SpringWorks Therapeutics logo
SpringWorks Therapeutics Series B round, April 2019 $125m
SpringWorks Therapeutics logo
SpringWorks Therapeutics funding round, September 2017 $103m

Industries

SpringWorks Therapeutics is active in the following industries:
  • Therapeutics
  • Engineering
  • Biomedical engineering
  • Technology
  • Biology
  • Biotechnology